Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease

In this discussion, Dr. Svati Shah, a cardiologist at Duke University and former chair of the American Heart Association Genomic and Precision Medicine Committee, sits down with Dr. Andrew Landstrom and Dr. Anwar Chahal to explore the rapidly advancing field of consumer genetic testing and provide guidance to clinicians whose patients may come to them with a report of incidentally identified variants that may impact their CVD risk. They converse about the challenges posed by the identification of genetic variants outside of the clinical setting, and how to interpret these variants. They further deliberate on setting a framework for evaluating the pathogenicity of variants, and ongoing patient care. The video serves as an essential resource for clinicians, scientists, and interested viewers wanting to understand the complexities of helping patients who come to them with these genetic test results.